UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation

Oncogene, 2008-09, Vol.27 (40), p.5348-5353

2008

Volltextzugriff (PDF)

Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence

Prostate cancer and prostatic diseases, 2010-12, Vol.13 (4), p.311-315

2010

Volltextzugriff (PDF)

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

Prostate cancer and prostatic diseases, 2010-09, Vol.13 (3), p.228-237

2010

Volltextzugriff (PDF)

Prediction of prostate cancer gleason score upgrading from biopsy to radical prostatectomy (RP) using a validated 17-gene panel assay

Annals of oncology, 2018-10, Vol.29, p.viii293-viii293

2018

Volltextzugriff (PDF)

Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: A population-based case-control study in China

Cancer research (Chicago, Ill.), 2000-09, Vol.60 (18), p.5111-5116

2000

Volltextzugriff (PDF)

Anterior tumors of the prostate: clinicopathological features and outcomes

Prostate cancer and prostatic diseases, 2014-03, Vol.17 (1), p.75-80

2014

Volltextzugriff (PDF)

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression

Prostate cancer and prostatic diseases, 2012-06, Vol.15 (2), p.150-156

2012

Volltextzugriff (PDF)

ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer

Prostate cancer and prostatic diseases, 2014-06, Vol.17 (2), p.126-131

2014

Volltextzugriff (PDF)

Variants in circadian genes and prostate cancer risk: a population-based study in China

Prostate cancer and prostatic diseases, 2008-12, Vol.11 (4), p.342-348

2008

Volltextzugriff (PDF)

PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer

Cancer research (Chicago, Ill.), 2000-12, Vol.60 (23), p.6568-6572

2000

Volltextzugriff (PDF)

CD34 IMMUNOHISTOCHEMICAL ASSESSMENT OF ANGIOGENESIS AS A PROGNOSTIC MARKER FOR PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY

The Journal of urology, 1998-08, Vol.160 (2), p.459-465

1998

Volltextzugriff (PDF)

A Novel Androgen-Regulated Gene, PMEPA1, Located on Chromosome 20q13 Exhibits High Level Expression in Prostate

Genomics (San Diego, Calif.), 2000-06, Vol.66 (3), p.257-263

2000

Volltextzugriff (PDF)

Metanephric adenoma. Clinicopathological study of fifty patients

The American journal of surgical pathology, 1995-10, Vol.19 (10), p.1101

1995

Volltextzugriff (PDF)

Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis

Cancer, 1998-09, Vol.83 (5), p.1002-1011

1998

Volltextzugriff (PDF)

PCGEM1, a Prostate-Specific Gene, Is Overexpressed in Prostate Cancer

Proceedings of the National Academy of Sciences - PNAS, 2000-10, Vol.97 (22), p.12216-12221

2000

Volltextzugriff (PDF)

Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate Cancer

The Journal of urology, 1996-10, Vol.156 (4), p.1511-1516

1996

Volltextzugriff (PDF)

Classification of Canine Urinary Bladder Urothelial Tumours Based on the World Health Organization/International Society of Urological Pathology Consensus Classification

Journal of comparative pathology, 2006-11, Vol.135 (4), p.190-199

2006

Volltextzugriff (PDF)

UP-02.195 Clinicopathological Correlation of ERG Protein Expression in Single Focus Prostate Cancer

Urology (Ridgewood, N.J.), 2011, Vol.78 (3), p.S329-S329

2011

Volltextzugriff (PDF)

Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers

Cancer research (Chicago, Ill.), 1994-06, Vol.54 (11), p.2861-2864

1994

Volltextzugriff (PDF)

Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy?

Journal of clinical pathology, 2008-09, Vol.61 (9), p.1038-1040

2008

Volltextzugriff (PDF)

Solitary pulmonary papillomas in adults: a clinicopathologic and in situ hybridization study of 14 cases combined with 27 cases in the literature

The American journal of surgical pathology, 1998-11, Vol.22 (11), p.1328-1342

1998

Volltextzugriff (PDF)

Interobserver reproducibility of Gleason grading of prostatic carcinoma: Urologic pathologists

Human pathology, 2001-01, Vol.32 (1), p.74-80

2001

Volltextzugriff (PDF)

EXPRESSION PROFILE OF AN ANDROGEN REGULATED PROSTATE SPECIFIC HOMEOBOX GENE NKX3.1 IN PRIMARY PROSTATE CANCER

The Journal of urology, 2000-03, Vol.163 (3), p.972-979

2000

Volltextzugriff (PDF)

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men

JAMA : the journal of the American Medical Association, 1995-10, Vol.274 (16), p.1277

1995

Volltextzugriff (PDF)

Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status

Prostate cancer and prostatic diseases, 2010-03, Vol.13 (1), p.47-51

2010

Volltextzugriff (PDF)

1 – 25 von 811

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(730)
Mit Volltextzugriff
(574)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation

Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

Prediction of prostate cancer gleason score upgrading from biopsy to radical prostatectomy (RP) using a validated 17-gene panel assay

Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: A population-based case-control study in China

Anterior tumors of the prostate: clinicopathological features and outcomes

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression

ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer

Variants in circadian genes and prostate cancer risk: a population-based study in China

PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer

CD34 IMMUNOHISTOCHEMICAL ASSESSMENT OF ANGIOGENESIS AS A PROGNOSTIC MARKER FOR PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY

A Novel Androgen-Regulated Gene, PMEPA1, Located on Chromosome 20q13 Exhibits High Level Expression in Prostate

Metanephric adenoma. Clinicopathological study of fifty patients

Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis

PCGEM1, a Prostate-Specific Gene, Is Overexpressed in Prostate Cancer

Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate Cancer

Classification of Canine Urinary Bladder Urothelial Tumours Based on the World Health Organization/International Society of Urological Pathology Consensus Classification

UP-02.195 Clinicopathological Correlation of ERG Protein Expression in Single Focus Prostate Cancer

Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers

Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy?

Solitary pulmonary papillomas in adults: a clinicopathologic and in situ hybridization study of 14 cases combined with 27 cases in the literature

Interobserver reproducibility of Gleason grading of prostatic carcinoma: Urologic pathologists

EXPRESSION PROFILE OF AN ANDROGEN REGULATED PROSTATE SPECIFIC HOMEOBOX GENE NKX3.1 IN PRIMARY PROSTATE CANCER

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men

Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status

Suchergebnisse filtern